Deals & Cases
IPO of ObsEva SALenz & Staehelin acted as Swiss counsel to ObsEva SA, a Geneva clinical-stage pharma company, which develops therapies for women's reproductive health. ObsEva raised USD 97 million in January 2017 by offering 6.5 million shares at USD 15 and will list on the Nasdaq. Lenz & Staehelin's corporate team was led by Jacques Iffland and included Sevan Antreasyan, Alix Farserotu and Emilie Jacot-Guillarmod. The firm's tax team was led by Jean-Blaise Eckert and included Rebecca Dorasamy and Jenny Benoît-Gonin.